Price $5.95 |
Market Cap
63.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.77
|
P/S
5.92
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-13.7K
|
FCF
-1.3
|
|
Op. Margin
-64.60%
|
Net Margin
-62.40%
|
ROE
-20.10%
|
ROI
-52.90%
|
|
ROA
-17.30%
|
EPS Growth
56.00%
|
Current Ratio
10.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chromadex Corp (CDXC) | $3.78 | - | - | 105.8M | Strong Buy |
| Bimi International Medical Inc (BIMI) | $1.10 | - | - | 6.4M | Strong Buy |
| iCAD Inc (ICAD) | $1.47 | - | - | 38.2M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $1.58 | - | - | 28.7M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $3.01 | - | - | 14.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
